Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs - AstraZeneca...
Benzinga· 22 hours agoAstraZeneca Plc AZN, Bristol Myers Squibb & Co BMY, and Boehringer Ingelheim are willing to...
Merck, AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiations
CNBC· 2 days agoMerck, AstraZeneca, Bristol Myers Squibb and Boehringer Ingelheim on Wednesday told CNBC they will...
Drugmakers face down deadline on Medicare price negotiations
The Hill via Yahoo News· 3 hours agoThe deadline for drugmakers to sign agreements to negotiate with Medicare on pricing is fast...
Eli Lilly, Boehringer Ingelheim’s Jardiance gets FDA approval for chronic kidney disease
Market Watch· 7 days agoand Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their...
Eli Lilly, Boehringer Ingelheim Get FDA OK for Jardiance in Chronic Kidney Disease
Morningstar· 7 days agoBy Colin Kellaher Eli Lilly and Boehringer Ingelheim have won expanded U.S. Food and Drug Administration approval of their blockbuster diabetes drug Jardiance for certain ...
Life Sciences BPO Market 2023 Recent Development and Business Scenario – Accenture, Boehringer ...
Digital Journal· 2 days agoAccording to industry estimates the Life Sciences BPO market growth is projected to expand between 13.34% CAGR during the 2023 to 2029 assessment period. Life Sciences BPO Market The global Life Sciences BPO market research report published by market
Empagliflozin Gets FDA Nod for CKD Without T2D or HF
Medscape· 2 days agoThe SGLT2 inhibitor empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) has received approval from the US Food and Drug Administration (FDA) for the...
Pharma’s big push for a new generation of obesity drugs
The Economist via AOL· 23 hours agoNow it puts the figure at $77bn. By comparison, last year they raked in just $2.4bn. The potential...
#UseHeart movement rallies for change as heart disease continues to claim most lives
CBS 47 Fresno· 5 hours agoThis World Heart Day, the World Heart Federation (WHF) is urging all sectors and citizens to join forces and take down cardiovascular disease (CVD) from its "number one killer" position. Conditions ...
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease
Zacks via Yahoo Finance· 4 days agoThe EU also approved the drug for heart failure and T2D indications. Lilly has developed Jardiance...
Yahoo Web Search
Trending Now
